Journals / Bağımlılık Dergisi / 2018 / Cilt: 19 - Sayı: 4

Acute and Chronic Effects of Cannabinoids on Learning and Memory Functions

Kannabinoidlerin Öğrenme ve Bellek İşlevleri Üzerindeki Akut ve Kronik Etkileri

Pages
123–135
Publication Date
2018-12-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this article is to review the current findings about the nature, size and reversibility of acute and chronic effects of cannabinoids on learning and memory functions and to discuss its relation with substance use characteristics.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cannabinoids have been associated with a wide range of pharmacological effects, some of which have potential therapeutic benefit while others result in negative outcomes, such as dependence and impaired cognition.
📊
Key Findings & Data:The most robust finding with respect to cognition is a deficit in working or short-term memory, which is a function requiring an intact hippocampus and prefrontal cortex, two brain regions richly expressing CB1 receptors.
💡
Conclusion & Impact:The aim of this article is to review the current findings about the nature, size and reversibility of acute and chronic effects of cannabinoids on learning and memory functions and to discuss its relation with substance use characteristics.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:dependence · elderly · alcohol use disorder

Abstract

Cannabinoids have been associated with a wide range of pharmacological effects, some of which have potential therapeutic benefit while others result in negative outcomes, such as dependence and impaired cognition. The most robust finding with respect to cognition is a deficit in working or short-term memory, which is a function requiring an intact hippocampus and prefrontal cortex, two brain regions richly expressing CB1 receptors. Starting with the discovery of an endogenous brain cannabinoid system with specific receptors, and their endogenous ligands and through the use of the tools such as specific CB1 receptor antagonist, and various transgenic models, considerable advances have been made in understanding the mechanisms underlying the effects of cannabinoids on memory. In studies that excluded the acute cannabis intoxication, chronic cannabis users’ poor performance on verbal learning and memory tasks reflect the potential chronic negatif effect of cannabinoids on learning and memory functions. Studies indicate the potential permanent side effects of cannabis use, especially during adolescence. The aim of this article is to review the current findings about the nature, size and reversibility of acute and chronic effects of cannabinoids on learning and memory functions and to discuss its relation with substance use characteristics.

Özet

Kannabinoidler klinik amaçlı kullanımlarının yanı sıra bilişsel işlevler üzerinde bozucu etki yaratmakta ve bağımlılık yapıcı potansiyelleriyle bilinmektedir. Kannabinoidlerin bilişsel işlevler üzerindeki en belirgin ve tutarlı negatif etkisi kısa süreli bellek veya çalışma belleği alanlarında görülmektedir. Bellek işlevlerinden sorumlu olan hipokampüs ve prefrontal korteks gibi alanların her ikisi de CB1 reseptörleri açısından zengin alanlardır. Özgül kannabinoid reseptörlerinin, bu reseptörlere bağlanan endojen ligandların ve seçici CB1 reseptör antagonisti ile transgenik modellerin sağladığı olanaklarla kannabinoidlerin öğrenme ve bellek işlevleri üzerindeki bozucu etkilerinin altında yatan nöral mekanizma konusunda önemli gelişmeler kaydedilmiştir. Akut madde intoksikasyonunun dışlandığı çalışmalarda ise kronik esrar kullanıcılarının sözel öğrenme ve bellek görevlerinde düşük performans göstermesi, kannabinoidlerin öğrenme ve bellek işlevleri üzerindeki potansiyel kronik negatif etkisini yansıtmaktadır. Çalışmalar özellikle ergenlik döneminde esrar kullanımının potansiyel kalıcı yan etkilerine işaret etmektedir. Bu makalenin amacı, kannabinoidlerin öğrenme ve bellek fonksiyonları üzerindeki hem akut hem de kronik etkisinin doğasını mevcut insan ve hayvan çalışmaları kapsamında olabildiğince kapsamlı bir şekilde incelemektir. Mevcut negatif etkinin boyutu, esrar kullanım özellikleriyle olan ilişkisi, esrar kullanımın sonlandırılmasıyla birlikte geriye döndürülebilir bir doğası olup olmadığı gibi sorular mevcut bulgular ışığında cevaplandırılmaya çalışılacaktır. Konunun özellikle ergenlik dönemindeki bireyler için eğitimsel doğurguları bulunmakla birlikte, dünyada esrar kullanımının yasallaştırılması yönündeki girişimler açısından da toplumsal önemi bulunmaktadır.

🔖

Cite This Article

ALKAN, B., ALICI, T. (2018). Acute and Chronic Effects of Cannabinoids on Learning and Memory Functions. Bağımlılık Dergisi, Cilt: 19 - Sayı: 4, 123–135. https://ajindex.com/articles/102749

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. United Nations Office on Drugs and Crime, World Drug Report 2017 (ISBN: 978-92-1-148291-1, eISBN: 978-92-1-060623-3,
  2. United Nations publication, Sales No. E.17.XI.6). Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA 2015; 313(24):2456-2473.
  3. ElSohly MA, Mehmedic Z, Foster S, et al. Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States. Biol Psychiatry 2016; 79(7):613-619.
  4. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964; 86(8):1646-1647.
  5. Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol. 2013; 64:21-47.
  6. Curran HV, Freeman TP, Mokrysz C, et al. Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci 2016; 17(5):293-306.
  7. Hillard CJ, Harris RA, Bloom AS. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies. J Pharmacol Exp Ther 1985; 232(3):579-588. Howlett AC. Cannabinoid inhibition of adenylate cyclase: biochemistry of the response in neuroblastoma cell membranes. Mol Pharmacol 1985; 27(4):429-436.
  8. Howlett AC, Qualy JM, Khachatrian LL. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 1986; 29(3):307-313.
  9. Devane WA, Dysarz FA, Johnson MR, et al. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988; 34(5):605-613.
  10. Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346(6284):561-564.
  11. Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993; 365(6441):61-65.
  12. Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310(5746):329-332. Pertwee RG. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tethrahydrocannabinol, cannabidiol and delta9-tethrahydrocannabinovarin. Br J Pharmacol 2008; 153(2):199-215.
  13. Glass M, Dragunow M, Faull RL. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience 1997; 77(2): 299-318.
  14. Herkenham M, Lynn AB, Little MD, et al. Cannabinoid receptor localization in brain. Proc Natl Aca